On-Pump Cardiopulmonary Bypass Versus Off-Pump Coronary Artery Bypass Grafting Surgery: Renal And Liver Function Tests
Abstract
Objective: Cardiopulmonary bypass (CPB) triggers systemic inflammation. Inflammatory system activation may cause deteoriation in liver and renal functions. In our study we aimed to search the effect of on-pump CPB and beating heart off-pump coronary artery bypass grafting (CABG) surgery techniques on renal and liver functions.
Methods: Sixty four patients who underwent coronary artery surgery were included in the study and were divided into two groups: on-pump CPB group (40) and beating heart off-pump CABG group (24), prospectively. The blood samples were collected for preoperative and postoperative levels of blood urea nitrogen (BUN), creatinine, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and AST to ALT ratio at 24th and 48th hours.
Results: Clinical and demographic features were similar in both groups. There were no statistically significant difference in levels of preoperative BUN, creatinine, AST, ALT, AST to ALT ratio. The postoperative 24th hour plasma levels of creatinine, AST and AST/ALT were lower in beating heart off-pump CABG group but BUN and ALT levels were similar among the two groups. The postoperative 48th hour plasma levels of BUN, creatinine, AST and AST/ALT were lower in beating heart off-pump CABG group but levels of ALT were similar in both groups.
Conclusion: Based on our findings we conclude that beating heart off-pump CABG has lower negative effect on liver and renal function than on-pump CPB.
Abstract of this manuscript was presented in 7th Congress of Update in Cardiology and Cardiovascular Surgery in association with TCT Mediterranean as a poster.
References
Chello M, Mastroroberto P, Quirino A, Cuda G, Perticone F, Cirillo F, et al. Inhibition of neutrophil apoptozis after coronary bypass operation with cardiopulmonary bypass. Ann Thorac Surg 2002;73:123-9.
Hazama S, Eishi K, Yamachika S, Noquchi M, Ariyoshi T, Takai H, et al. Inflammatory response after coronary revascularization: off-pump versus on-pump (heparin coated circuits and poly2 methoxyethylacilate coated circuits) Ann Thorac Surg 2004;10:90-6.
Stamou SC, Corso PJ. Coronary revascularization without cardiopulmonary bypass in high-risk patients: A route to the future. Ann Thorac Surg 2001;71:1056-61.
Kiziltepe U, Tasoz R, Aral A, Elalmis AO, Eyileten ZB, Sirlak M et al. Clinical effects of combination of steroids and antioxidants following coronary artery bypass surgery. Turkiye Klinikleri J Cardiovascular Surgery 2003;4:33-9.
Ricci M, Karamanukian HL, Abraham R, Von Fricken K, D’Ancona G, Choi S, et al. Stroke in octogenarians undergoing coronary artery surgery with and without cardiopulmonary bypass. Ann Thorac Surg 2000;69:1471-5.
Koutlas TC, Elbeery JR, Williams JM, Moran JF, Francalancia NA, Chitwood WR Jr. Myocardial revascularization in the elderly using beating heart coronary artery bypass surgery. Ann Thorac Surg 2000;69(4):1042-7.
Butler J, Rocker GM, Westaby S. Inflammatory response to cardiopulmonary bypass. Ann Thorac Surg 1993;55:552-9.
Khabar KS, elBarbary MA, Khouqeer F, Devol E, al-Gain S, al-Halees Z. Circulating endotoxin and cytokines after cardiopulmonary bypass: differential correlation with duration of bypass and systemic inflammatory response/ multiple organ dysfunction syndromes. Clin Immunol Immunopathol 1997;85:97-103.
Yucel SM, Keceligil HT. Cardiopulmonary bypass. Turkiye Klinikleri J Cardiovasc Surg-Special Topics 2013;5:5-8.
Okubo N, Hatori N, Ochi M, Tanaka S. Comparison of m-RNA expression for inflammatory mediators in leukocytes between on-pump and off-pump coronary artery bypass grafting. Ann Torac Cardiovasc Surg 2003;9:43-9.
Onorati F, Rubino AS, Nucera S, Foti D, Sica V, Santini F, et al. Off-pump coronary artery bypass surgery versus standard linear or pulsatile cardiopulmonary bypass: endothelial activation and inflammatory response. Eur J Cardiothorac Surg. 2010;37:897-904.
Ascione R, Talpahewa S, Rajakaruna C, Reeves BC, Lovell AT, Cohen A, et al. Splanchnic organ injury during coronary surgery with or without cardiopulmonary bypass: a randomized, controlled trial. Ann Thorac Surg. 2006;81:97-103.
Yamada T, Ochiai R, Takeda J, Kikuchi H, Ishibashi M, Watanabe K. Off-pump coronary artery bypass attenuates transient hepatocellular damage after myocardial revascularization. J Cardiothorac Vasc Anesth. 2005;19:603-7.
O'Dwyer C, Woodson LC, Conroy BP, Lin CY, Deyo DJ, Uchida T, et al. Regional perfusion abnormalities with phenylephrine during normothermic bypass. Ann Thorac Surg. 1997;63:728-35.
Lefor AT, Vuocolo P, Parker FB Jr, Sillin LF. Pancreatic complications following cardiopulmonary bypass Factors influencing mortality. Arch Surg. 1992;127:1225-30.
Wang MJ, Chao A, Huang CH, Tsai CH, Lin FY, Wang SS, et al. Hyperbilirubinemia after cardiac operation. Incidence, risk factors, and clinical significance. J Thorac Cardiovasc Surg. 1994;108:429-36.
Riddington DW, Venkatesh B, Boivin CM, Bonser RS, Elliott TS, Marshall T, et al. Intestinal permeability, gastric intramucosal pH, and systemic endotoxemia in patients undergoing cardiopulmonary bypass. JAMA. 1996;275:1007-12.
Loef BG, Epema AH, Navis G, Ebels T, van Oeveren W, Henning RH. Off-pump coronary revascularization attenuates transient renal damage compared with on-pump coronary revascularization. Chest. 2002;121:1190-4.
Pramodh K, Vani, Muralidhar K. Renal function following CABG: On-pump vs off-pump. Ind J Thorac Cardiovasc Surg 2003;19:169-73.
Mangano CM, Diamondstone LS, Ramsay JG, Aggarwal A, Herskowitz A, Mangano DT. Renal dysfunction after myocardial revascularization: risk factors, adverse outcomes, and hospital resource utilization. The Multicenter Study of Perioperative Ischemia Research Group. Ann Intern Med. 1998;128:194-203.
Conlon PJ, Stafford-Smith M, White WD, Newman MF, King S, Winn MP, et al. Acute renal failure following cardiac surgery. Nephrol Dial Transplant. 1999;14:1158-62.
Boodhwani M, Rubens FD, Wozny D, Nathan H. Effects of mild hypothermia and rewarming on renal function after coronary artery bypass grafting. Ann Thorac Surg. 2009;87:489-95.
Shahbazi S, Parah A, Sahmeddini MA. Evaluation of factors influencing liver function test in on-pump coronary artery bypass graft surgery. Iran J Med Sci 2013;38:308-13.
Bierbach B, Bomberg H, Pritzer H, Prabhu S, Petzina R, Kempski O, Horstick G, Cremer J, Hoffmann G. Off-pump coronary artery bypass prevents visceral organ damage. Interact Cardiovasc Thorac Surg. 2014;18:717-26.
